Company intelligence / Profile preview

Holistic Health International

Bethel, Maine, USA

Ownership: Private
Development stage: Other

Overview

Holistic Health International provides proprietary genetic tests and supplements developed under Dr. Amy Yasko’s protocols, focusing on personalized health, chemical sensitivities, and methylation support; data-driven, well regarded in niche wellness circles, with over two decades of customer feedback and commercial success

Therapeutic areas: OtherNeurologyImmunologyMetabolic Disorders
Modalities: Small moleculeDeviceNutritional supplement
Industry: Molecular Diagnostics

Partnerships

No major biotech/pharma partnerships reported—focused on direct-to-consumer and practitioner network

Beyond the preview

Go deeper on Holistic Health International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Holistic Health International.

Explore the full profile